Nello Mainolfi Kymera Therapeutics, Inc. (KYMR) insider trading activity

Nello Mainolfi is Chief Executive Officer of Kymera Therapeutics, Inc.. Currently has a direct ownership of 663,077 shares of KYMR, which is worth approximately $43.1 Million. The most recent transaction as insider was on Jun 10, 2021, when has been sold 23,009 shares (Common Stock) at a price of $51.54 per share, resulting in proceeds of $1,185,884. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 663K

0.39% 3M change

2.02% 12M change

Total Value Held $43.1 Million

Nello Mainolfi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 10 2021	SELL Open market or private sale	$1,185,884 $51.54 p/Share	23,009 Reduced 5.29%	412,199 Common Stock
Jun 10 2021	BUY Exercise of conversion of derivative security	$47,859 $2.08 p/Share	23,009 Added 5.02%	435,208 Common Stock
Jun 09 2021	SELL Open market or private sale	$287,715 $50.02 p/Share	5,752 Reduced 1.38%	412,199 Common Stock
Jun 09 2021	BUY Exercise of conversion of derivative security	$11,964 $2.08 p/Share	5,752 Added 1.36%	417,951 Common Stock
Jun 08 2021	SELL Open market or private sale	$13,500 $50.0 p/Share	270 Reduced 0.07%	412,199 Common Stock
Jun 08 2021	BUY Exercise of conversion of derivative security	$562 $2.08 p/Share	270 Added 0.07%	412,469 Common Stock
Jun 07 2021	SELL Open market or private sale	$637,981 $50.14 p/Share	12,724 Reduced 2.99%	412,199 Common Stock

Jun 07 2021	BUY Exercise of conversion of derivative security	$26,466 $2.08 p/Share	12,724 Added 2.91%	424,923 Common Stock
May 19 2021	BUY Exercise of conversion of derivative security	$31,200 $2.08 p/Share	15,000 Added 3.51%	412,199 Common Stock
May 12 2021	SELL Open market or private sale	$412,662 $50.05 p/Share	8,245 Reduced 2.03%	397,199 Common Stock
May 12 2021	BUY Exercise of conversion of derivative security	$17,150 $2.08 p/Share	8,245 Added 1.99%	405,444 Common Stock
Apr 26 2021	SELL Open market or private sale	$111,218 $40.18 p/Share	2,768 Reduced 0.69%	397,199 Common Stock
Apr 26 2021	BUY Exercise of conversion of derivative security	$5,757 $2.08 p/Share	2,768 Added 0.69%	399,967 Common Stock
Apr 23 2021	SELL Open market or private sale	$27,207 $40.01 p/Share	680 Reduced 0.17%	397,199 Common Stock
Apr 23 2021	BUY Exercise of conversion of derivative security	$1,414 $2.08 p/Share	680 Added 0.17%	397,879 Common Stock
Apr 22 2021	SELL Open market or private sale	$441,209 $40.26 p/Share	10,959 Reduced 2.68%	397,199 Common Stock
Apr 22 2021	BUY Exercise of conversion of derivative security	$22,795 $2.08 p/Share	10,959 Added 2.61%	408,158 Common Stock
Apr 19 2021	SELL Open market or private sale	$26,120 $40.0 p/Share	653 Reduced 0.17%	391,199 Common Stock
Apr 19 2021	BUY Exercise of conversion of derivative security	$13,838 $2.08 p/Share	6,653 Added 1.65%	397,199 Common Stock
Apr 15 2021	SELL Open market or private sale	$199,033 $40.29 p/Share	4,940 Reduced 1.25%	391,199 Common Stock
Apr 15 2021	BUY Exercise of conversion of derivative security	$10,275 $2.08 p/Share	4,940 Added 1.23%	396,139 Common Stock
Apr 13 2021	BUY Exercise of conversion of derivative security	$31,200 $2.08 p/Share	15,000 Added 3.69%	391,199 Common Stock
Apr 12 2021	SELL Open market or private sale	$500,910 $32.81 p/Share	15,267 Reduced 3.9%	376,199 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$31,755 $2.08 p/Share	15,267 Added 3.75%	391,466 Common Stock
Apr 09 2021	SELL Open market or private sale	$772,489 $33.89 p/Share	22,794 Reduced 5.71%	376,199 Common Stock

Nello Mainolfi

Chief Executive Officer

Watertown, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KYMR shares.

Notify only if

Value

Insider Trading

Get notified when an Kymera Therapeutics, Inc. insider buys or sells KYMR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kymera Therapeutics, Inc.

Track Activities on KYMR

Account